Some of the therapeutic drugs such as interferon-α (IFN-α) for hairy cell leukemia (3), interleukin-2 (IL-2) for metastatic renal cancer and metastatic melanoma (4) have been approved by the US Food and Drug Administration (FDA), and has achieved certain remission in some patients. The gene discussed is IL2; the disease is metastatic melanoma.